For the peptide studies (Table 1, n = 11), extracted information included study characteristics such as author, year, country, and design
Journal of Physiology and Pharmacology , 74(2), 231249
Retatrutide is an unlicensed investigational peptide in the UK with no MHRA or EMA marketing authorisation as of 2024
Our COA guide explains how to read HPLC chromatograms, mass-spec identity confirmation, and purity figures so you can verify the material meets your experimental requirements before use in the laboratory
The key takeaway here is that any compound suspected of causing gyno must, through some mechanism, either dramatically increase estrogen, mimic estrogen, decrease testosterone significantly, or elevate prolactin
For example: 2.5 mg from a 5 mg/mL vial = 50 units 2.5 mg from a 10 mg/mL vial = 25 units 2.5 mg from a 20 mg/mL vial = 12.5 units This is why patients should never copy someone elses dosing instructions